share_log

荣昌生物制药(烟台)股份有限公司2024年半年度报告摘要

Summary of Remegen (Yantai) Co., Ltd.'s 2024 Interim Report

SZSI ·  Aug 16, 2024 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more